Press Release

Alvarez & Marsal Scales Healthcare Practice with Four Strategic Hires Focused on Health Plans and Managed Care

Issued by Alvarez & Marsal

July 28, 2025

These senior additions enhance A&M’s full range of end-to-end advisory services for payers navigating cost, economic and regulatory uncertainties.

New York – Leading global professional services firm Alvarez & Marsal (A&M) today announced significant expansion within its Health Plans and Managed Care practice. Joining the firm are Managing Directors Michael Epstein and Jim Collier, alongside Senior Directors Brent Hill and Todd Masser, enhancing A&M’s capability to deliver tailored, actionable solutions driving client growth.

“Healthcare payers and risk-bearing entities (RBEs), already contending with considerable financial, operational and regulatory pressures must now prepare for the additional complexities arising from the projected $1 trillion reduction in federal Medicaid funding over the next decade," said Craig Savage, Managing Director and Leader of the Health Plans and Managed Care Practice at A&M. "As outlined in our recent thought leadership paper, 'Impending Medicaid Funding Reductions and the Strategic Implications for Health Plans, State Budgets and Vulnerable Populations,' strategic foresight and operational excellence are critical for organizations to successfully navigate these complex dynamics. Our new colleagues deepen our ability to deliver practical, sustainable results.”

Martin McGahan, Managing Director and Head of A&M’s Healthcare Industry Group added, "The addition of these senior leaders underscores our commitment to expanding our Healthcare Industry Group in response to market demands. The growth and cross-collaboration of our Health Plans and Managed Care practice with our Health Systems and Healthcare Services and Private Equity teams exemplify our holistic approach to addressing healthcare's evolving landscape. These strategic hires will further enhance our integrated capabilities across the entire healthcare spectrum."

Mr. Epstein, Mr. Collier, Mr. Hill, and Mr. Masser collectively bring decades of specialized expertise advising national and regional health plans, provider-sponsored plans, public payers, and integrated delivery networks. Their combined experience includes strategic planning, medical management optimization, population health strategy, Medicaid and Medicare Advantage program improvement, and operational cost containment.

Mr. Collier joins A&M from Wipro LLC, where he was Senior Partner and Global Healthcare Industry Consulting Practice Lead. He previously held leadership roles at Walgreens Boots Alliance, NTT DATA Services, and Accenture.

Mr. Epstein previously served as Managing Director of The Tay Group, with prior leadership roles at Deloitte Consulting and WellPoint (now Elevance Health).

Mr. Hill joins from CVS Health, where he was Strategy Execution Lead, with prior roles at Optum, Willis Towers Watson, and Evolent Health.

Mr. Masser brings extensive clinical and technology operations experience from his 18-year tenure at UnitedHealth Group, most recently serving as Vice President of Advisory Services at Optum.

About Alvarez & Marsal

Founded in 1983, Alvarez & Marsal is a leading global professional services firm. Renowned for its leadership, action, and results, Alvarez & Marsal provides advisory, business performance improvement, and turnaround management services, delivering practical solutions to address clients' unique challenges. With a worldwide network of experienced operators, world-class consultants, former regulators, and industry authorities, Alvarez & Marsal helps corporates, boards, private equity firms, law firms, and government agencies drive transformation, mitigate risk, and unlock value at every stage of growth. To learn more, visit: AlvarezandMarsal.com

Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink.